Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization
Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
Enhance muscular development
The solution should be clear and colorless when ready
2003 Oct;24(5):329-33
Restore and maintain proper hydration levels to help your body function at its best Quick support that works
